SXTC
China SXT Pharmaceuticals, Inc. NASDAQ Listed Jan 4, 2019$1.66
Mkt Cap $1.3M
52w Low $1.25
0.0% of range
52w High $1047.00
50d MA $1.94
200d MA $138.27
P/E (TTM)
-0.2x
EV/EBITDA
-52.1x
P/B
0.1x
Debt/Equity
0.1x
ROE
-21.4%
P/FCF
-64.4x
RSI (14)
—
ATR (14)
—
Beta
1.75
50d MA
$1.94
200d MA
$138.27
Avg Volume
239.3K
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
178 Taidong Road North · Taizhou 225300 · CN
Data updated apr 24, 2026 10:38am
· Source: massive.com